Search

Proposals received through the Community Research Priorities Portal are assessed and prioritised by the TCR Prioritisation Committee using this rubric.

NHMRC's vision is a gender diverse and inclusive health and medical research workforce to take advantage of the full range of talent needed to build a healthy Australia.   NHMRC has completed its consultation on options to reach gender equity in the NHMRC Investigator Grant scheme.

NHMRC offers a range of funding pathways, depending on your objectives, funding amount, timeframes and other preferences. The Partnering Decision Tree  below presents potential partners with options to assist in making a decision on the type of funding model to adopt.

The Privacy Legislation Amendment Act 2006 (Cth) made changes to the Privacy Act 1988(Cth) (the Privacy Act) to allow health practitioners to disclose patient’s genetic information, whether or not they give consent, in circumstances where there is reasonable belief that doing so is necessary to lessen or prevent a serious threat to the life, health or safety of their genetics relative(s).  The amendments do not oblige disclosure of information but provide the framework for this to occur under the appropriate circumstances.

The Australian Government Department of Health and Aged Care (the department) and National Health and Medical Research Council (NHMRC) undertook consultation processes to provide an opportunity for members of the public, peak bodies, experts and other interested stakeholders to consider mitochondrial donation in the Australian context.

MRFF Grants administered by NHMRC are offered in accordance with the MRFF Funding Agreement (November 2021) between the Australian Government Department of Health and Aged Care and the MRFF Eligible Organisation.

Influenza pandemics have caused death and social tragedy for hundreds of years, and the control of influenza was a priority for health and medical researchers in Australia during the twentieth century. From the 1930s to the 1960s, Frank Macfarlane Burnet and his team of NHMRC-funded researchers at The Walter and Eliza Hall Institute (WEHI) made major contributions to our understanding of the influenza virus and how to prevent and treat infection. 

The Patient Blood Management Guidelines (the Guidelines) were developed following increasing evidence of transfusion-related adverse outcomes, leading to the emergence of new practices, including restrictive transfusion strategies and the increased use of alternatives to transfusion in the management of anaemia. 

Haemolytic disease of the fetus and newborn (HDFN, also known as Rh Disease) can occur during pregnancy when a pregnant woman’s immune system produces antibodies that attack their fetus’ red blood cells (RBCs). Once a major cause of fetal and newborn mortality, today HDFN is almost non-existent in Australia due to routine antenatal blood grouping and antibody screening, and the use of prophylactic Rh D immunoglobulin and appropriate clinical management of mother and baby. Guidelines, initially produced by NHMRC on behalf of the Department of Health and Ageing, have assisted with translation of the research on Rh D antibody screening and Rh D immunoglobin into clinical practice.

For the review of the evidence for dietary guidance for older Australians.Published in June 2024.

The Water Quality Advisory Committee provides expert advice on drinking water quality and public health.

More than 400,000 Australians are living with dementia. It is Australia's second overall leading cause of burden of disease in injury, behind coronary heart disease.1 A long-term approach to the diagnosis and treatment of dementia is essential for Australia's social and economic wellbeing.

Associate Professor Odette Pearson is of Eastern Yalanji and Torres Strait Islander descent and coleads the Aboriginal Health Equity Theme, South Australian Health and Medical Research Institute. Her research focus is improving chronic disease and ageing outcomes of Aboriginal and Torres Strait Islander peoples through policy and guideline development and implementing and evaluating real world health and social interventions. Aboriginal leadership, governance and community and cross sector partnerships are foundations of her research. A/Prof Pearson has received the Lowitja Institute Patricia Anderson Leader in Aboriginal Research (2023), UniSA Alumini Award for Research in Aboriginal Health (2022) and The Diane Ranck, SAHMRI award for Leadership in Research (2022).

NHMRC is serious about preventing, detecting and responding to fraud and corruption and is committed to high ethical, moral and legal standards. A key focus of this framework is to raise awareness of fraud and corruption among NHMRC employees and other people who deal with NHMRC, and to assist in the prevention, detection and reporting of suspected fraud and corrupt conduct.

Neurodegenerative diseases such as Alzheimer’s, Motor Neurone and Parkinson’s disease affect millions of people around the world and place an enormous burden on the Australian healthcare system.